| Brooks P Landy, DPT | |
|
75 Jones And Gifford Ave, Jamestown, NY 14701-2828 | |
| (716) 661-1541 | |
| Not Available |
| Full Name | Brooks P Landy |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 12 Years |
| Location | 75 Jones And Gifford Ave, Jamestown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124371398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | P86170 (New York) | Secondary |
| 225100000X | Physical Therapist | PT28647 (Florida) | Secondary |
| 225100000X | Physical Therapist | 035860 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rsfh - Ati Physical Therapy Llc | 3375849946 | 76 |
News Archive
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is proud to sponsor several key sets of Cimzia (certolizumab pegol) data at the American College of Rheumatology's 2011 Annual Scientific Meeting in Chicago, November 5-9.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a $733,438 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA).
The White House will unveil the first formal national HIV/AIDS strategy on Tuesday, a plan that aims to reduce the number of new cases by 25 percent in the next five years, officials said. Noting that the number of new infections in the United States has been static - and that the number of people living with HIV is growing - the new policy would direct more resources toward African Americans and gay and bisexual men. Latinos and substance abusers should also be a priority, the report says.
› Verified 5 days ago
| Provider Name | Rsfh - Ati Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1912378365 PECOS PAC ID: 3375849946 Enrollment ID: O20160308000885 |
News Archive
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is proud to sponsor several key sets of Cimzia (certolizumab pegol) data at the American College of Rheumatology's 2011 Annual Scientific Meeting in Chicago, November 5-9.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a $733,438 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA).
The White House will unveil the first formal national HIV/AIDS strategy on Tuesday, a plan that aims to reduce the number of new cases by 25 percent in the next five years, officials said. Noting that the number of new infections in the United States has been static - and that the number of people living with HIV is growing - the new policy would direct more resources toward African Americans and gay and bisexual men. Latinos and substance abusers should also be a priority, the report says.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooks P Landy, DPT Po Box 1705, Cody, WY 82414-1705 Ph: (307) 587-9866 | Brooks P Landy, DPT 75 Jones And Gifford Ave, Jamestown, NY 14701-2828 Ph: (716) 661-1541 |
News Archive
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is proud to sponsor several key sets of Cimzia (certolizumab pegol) data at the American College of Rheumatology's 2011 Annual Scientific Meeting in Chicago, November 5-9.
POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a $733,438 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA).
The White House will unveil the first formal national HIV/AIDS strategy on Tuesday, a plan that aims to reduce the number of new cases by 25 percent in the next five years, officials said. Noting that the number of new infections in the United States has been static - and that the number of people living with HIV is growing - the new policy would direct more resources toward African Americans and gay and bisexual men. Latinos and substance abusers should also be a priority, the report says.
› Verified 5 days ago
Mr. Michael Carl Peterson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2850 Mitchell Rd, Jamestown, NY 14701 Phone: 716-487-1713 | |
Akashdeep Kaur-brar, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 774 Fairmount Ave, Jamestown, NY 14701 Phone: 716-665-1166 | |
Raymond Lukach, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 Jones And Gifford Ave, Jamestown, NY 14701 Phone: 716-661-1541 | |
Mr. Jacob Christopher Mcbride, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15 S Main Street, Suite 220, Jamestown, NY 14701 Phone: 716-488-2322 Fax: 716-488-2574 | |
William Bowler, MS Physical Therapist Medicare: Medicare Enrolled Practice Location: 75 Jones And Gifford Ave, Jamestown, NY 14701 Phone: 716-661-1541 | |
Megan E Mckinley, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 75 Jones And Gifford Ave, Jamestown, NY 14701 Phone: 716-661-1541 | |
Leandra Nicole St. Pierre, DPT, CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 S Main St, Suite 220, Jamestown, NY 14701 Phone: 716-488-2322 Fax: 716-488-2574 |